What is NDC 82293-011?

82293-011 is the product NDC for Lenalidomide, Lenalidomide 25 mg/1 capsule, listed with the FDA by Novugen Pharma (USA) LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Novugen Pharma (USA) LLC, NDC labeler code 82293. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lenalidomide?

107 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lenalidomide NDC 82293-011 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)82293-011Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82293-0011Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82293-011-10	8229300111082293001110	21 CAPSULE in 1 BOTTLE (82293-011-10)Marketed from Jan 6, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lenalidomide
Generic name (nonproprietary): lenalidomide
Active ingredients: Lenalidomide — 25 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Novugen Pharma (USA) LLCNDC labeler code 82293
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217281
Marketing start: Jan 6, 2026
Listing expires: Dec 31, 2026
Identifiers: Product ID 82293-011_4531a3e4-1189-0276-e063-6394a90aedfdSPL ID 4531a3e4-1189-0276-e063-6394a90aedfdSPL set ID 2166bbdf-eb12-4564-b9e4-b63ca21312bcRxCUI 602910, 602912, 643712, 643720, 1242231, 1428947UNII F0P408N6V4UPC 0382293011100, 0382293008100, 0382293007103
Pharmacologic class: Thalidomide Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482293001110 followed by a unit qualifier and the quantity

Package 82293-0011-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 23, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Lenalidomide is a thalidomide analogue indicated for the treatment of adult patients with: Multiple myeloma (MM), in combination with dexamethasone ( 1.1 ). MM, as maintenance following autologous hematopoietic stem cell transplantation (auto-HSCT) ( 1.1 ). Transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q abnormality with or without additional cytogenetic abnormalities ( 1.2 ). Mantle cell lymphoma (MCL) whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib ( 1.3 ). Previously treated follicular lymphoma (FL), in combination with a rituximab product ( 1.4 ). Previously …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 82293-011

What is NDC 82293-011?: 82293-011 is the product NDC for Lenalidomide, Lenalidomide 25 mg/1 capsule, listed with the FDA by Novugen Pharma (USA) LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lenalidomide.
What is the active ingredient?: Lenalidomide.
Who is the labeler?: Novugen Pharma (USA) LLC, NDC labeler code 82293. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lenalidomide?: 107 other product NDCs are listed under this name. See all Lenalidomide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lenalidomide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lenalidomide	Lenalidomide 2.5 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-692	16729-0692-09
Lenalidomide	Lenalidomide 25 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-697	16729-0697-06
Lenalidomide	Lenalidomide 15 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-695	16729-0695-06
Lenalidomide	Lenalidomide 5 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-693	16729-0693-09
Lenalidomide	Lenalidomide 20 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-696	16729-0696-06
Lenalidomide	Lenalidomide 10 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-694	16729-0694-09
Lenalidomide	Lenalidomide 2.5 mg/1	CapsuleOral	Padagis US LLC	0574-1402	00574-1402-28
Lenalidomide	Lenalidomide 5 mg/1	CapsuleOral	Padagis US LLC	0574-1405	00574-1405-28
Lenalidomide	Lenalidomide 10 mg/1	CapsuleOral	Padagis US LLC	0574-1410	00574-1410-28
Lenalidomide	Lenalidomide 15 mg/1	CapsuleOral	Padagis US LLC	0574-1415	00574-1415-21

All 108 Lenalidomide NDCs

Other NDCs under ANDA 217281

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217281
Product	Strength	Form · route	Labeler	Product NDC
Lenalidomide	Lenalidomide 2.5 mg/1	CapsuleOral	Novugen Pharma (USA) LLC	82293-006
Lenalidomide	Lenalidomide 5 mg/1	CapsuleOral	Novugen Pharma (USA) LLC	82293-007
Lenalidomide	Lenalidomide 10 mg/1	CapsuleOral	Novugen Pharma (USA) LLC	82293-008
Lenalidomide	Lenalidomide 15 mg/1	CapsuleOral	Novugen Pharma (USA) LLC	82293-009
Lenalidomide	Lenalidomide 20 mg/1	CapsuleOral	Novugen Pharma (USA) LLC	82293-010